Literature DB >> 6323064

Histological classification of pituitary disease.

S L Asa, K Kovacs.   

Abstract

Morphological features of pituitary disease are classified according to increased and decreased hormone production to allow clinical correlation with pathological processes. Increased hormone synthesis and secretion may be due to pituitary adenomas or carcinomas derived from the five hormone-secreting cell types, or to extrapituitary stimuli causing hypertrophy and hyperplasia of those cells. Various tumour-like conditions can mimic functioning adenomas. Rarely, no lesion is detected and intrinsic abnormalities of adenohypophyseal cells are implicated. Hypopituitarism can be selective or generalized. Diffuse hormone deficiency is usually attributable to tissue destruction by tumours, inflammatory or infiltrative conditions or vascular lesions. Congenital abnormalities of pituitary development may result in hypophyseal dysfunction. Hypothalamic abnormalities may cause generalized hypopituitarism or may involve only selective releasing factors and hormones. Feedback inhibition and receptor abnormalities may be implicated in pituitary hypofunction, and selective deficiencies may be the result of genetic abnormalities, immune reactions or toxic damage to one cell type.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6323064     DOI: 10.1016/s0300-595x(83)80056-5

Source DB:  PubMed          Journal:  Clin Endocrinol Metab        ISSN: 0300-595X


  9 in total

1.  Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.

Authors:  E Thodou; G Kontogeorgos; E Kyrodimou; H Salla; L Ramyar; E Vamvassakis; G Piaditis; N Anagnostopoulos; S Tzanis; A Levedis; D Rologis; S L Asa
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  A case of Rathke's cleft cyst within a pituitary adenoma presenting with acromegaly--do "transitional cell tumors of the pituitary gland" really exist?

Authors:  H Ikeda; T Yoshimoto; R Katakura
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 3.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

Review 4.  Prolactinomas.

Authors:  A Grossman; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

5.  Pituitary adenomas in patients under 20 years old. A clinicopathological study of 12 cases.

Authors:  K Mukai; E L Seljeskog; L P Dehner
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

Review 6.  Diagnosis and drug therapy of prolactinoma.

Authors:  E Ciccarelli; F Camanni
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

Review 7.  In search of a prognostic classification of endocrine pituitary tumors.

Authors:  Jacqueline Trouillas
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

Review 8.  Aggressive pituitary neuroendocrine tumors: current practices, controversies, and perspectives, on behalf of the EANS skull base section.

Authors:  Sam Ng; Mahmoud Messerer; Julien Engelhardt; Michaël Bruneau; Jan Frederick Cornelius; Luigi Maria Cavallo; Giulia Cossu; Sebastien Froelich; Torstein R Meling; Dimitrios Paraskevopoulos; Henry W S Schroeder; Marcos Tatagiba; Idoya Zazpe; Moncef Berhouma; Roy T Daniel; Edward R Laws; Engelbert Knosp; Michael Buchfelder; Henri Dufour; Stéphane Gaillard; Timothée Jacquesson; Emmanuel Jouanneau
Journal:  Acta Neurochir (Wien)       Date:  2021-08-08       Impact factor: 2.816

9.  Elevated proenkephalin-derived peptide levels in ACTH-producing adenomas: nucleus and cytoplasm localization.

Authors:  O Vindrola; A Chervin; M Vitale; A N Mella; R Aloyz; A Basso
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.